Estradiol/levonorgestrel transdermal - Labtec

Drug Profile

Estradiol/levonorgestrel transdermal - Labtec

Alternative Names: Estradiol + levonorgestrel transdermal - Labtec; Levonor TDS; Levonorgestrel + estradiol transdermal - Labtec; Levonorgestrel/estradiol transdermal - Labtec

Latest Information Update: 12 Nov 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Labtec
  • Class Estradiol congeners; Estrenes; Hormonal replacements; Norpregnanes; Small molecules
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Menopausal syndrome

Most Recent Events

  • 02 Jan 2007 Registered for Menopausal syndrome in the European Union under the mutual recognition procedure with Sweden as the reference member state (Transdermal)
  • 11 May 2006 This product is still under review for approval in the European Union
  • 31 Mar 2004 This product has been filed for approval within the European Union through the mutual recognition procedure; Sweden is acting as the reference member state
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top